488 related articles for article (PubMed ID: 28229932)
21. Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5.
Altmann E; Erbel P; Renatus M; Schaefer M; Schlierf A; Druet A; Kieffer L; Sorge M; Pfister K; Hassiepen U; Jones M; Ruedisser S; Ostermeier D; Martoglio B; Jefferson AB; Quancard J
Angew Chem Int Ed Engl; 2017 Jan; 56(5):1294-1297. PubMed ID: 27981705
[TBL] [Abstract][Full Text] [Related]
22. Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response.
Lee YH; Judge AD; Seo D; Kitade M; Gómez-Quiroz LE; Ishikawa T; Andersen JB; Kim BK; Marquardt JU; Raggi C; Avital I; Conner EA; MacLachlan I; Factor VM; Thorgeirsson SS
Oncogene; 2011 Oct; 30(40):4175-84. PubMed ID: 21499307
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatical identification of key pathways and genes in human hepatocellular carcinoma after CSN5 depletion.
Fu Q; Yang F; Zhao J; Yang X; Xiang T; Huai G; Zhang J; Wei L; Deng S; Yang H
Cell Signal; 2018 Sep; 49():79-86. PubMed ID: 29885455
[TBL] [Abstract][Full Text] [Related]
24. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
[TBL] [Abstract][Full Text] [Related]
26. 14-3-3ζ targeting induced senescence in Hep-2 laryngeal cancer cell through deneddylation of Cullin1 in the Skp1-Cullin-F-box protein complex.
Seo SB; Baek JY; Lim JH; Jin X; Lee MY; Lee JH
Cell Prolif; 2019 Sep; 52(5):e12654. PubMed ID: 31222857
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.
Asare Y; Ommer M; Azombo FA; Alampour-Rajabi S; Sternkopf M; Sanati M; Gijbels MJ; Schmitz C; Sinitski D; Tilstam PV; Lue H; Gessner A; Lange D; Schmid JA; Weber C; Dichgans M; Jankowski J; Pardi R; de Winther MP; Noels H; Bernhagen J
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2766-E2775. PubMed ID: 28292897
[TBL] [Abstract][Full Text] [Related]
28. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer.
Guo Z; Zhou C; Zhou L; Wang Z; Zhu X; Mu X
Cell Immunol; 2022 Feb; 372():104469. PubMed ID: 35114597
[TBL] [Abstract][Full Text] [Related]
30. Structural and biochemical characterization of the Cop9 signalosome CSN5/CSN6 heterodimer.
Birol M; Enchev RI; Padilla A; Stengel F; Aebersold R; Betzi S; Yang Y; Hoh F; Peter M; Dumas C; Echalier A
PLoS One; 2014; 9(8):e105688. PubMed ID: 25144743
[TBL] [Abstract][Full Text] [Related]
31. Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
Fillmore RA; Mitra A; Xi Y; Ju J; Scammell J; Shevde LA; Samant RS
Int J Cancer; 2009 Aug; 125(3):556-64. PubMed ID: 19358268
[TBL] [Abstract][Full Text] [Related]
32. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
[TBL] [Abstract][Full Text] [Related]
33. The COP9 signalosome reduces neuroinflammation and attenuates ischemic neuronal stress in organotypic brain slice culture model.
Tian Y; Milic J; Monasor LS; Chakraborty R; Wang S; Yuan Y; Asare Y; Behrends C; Tahirovic S; Bernhagen J
Cell Mol Life Sci; 2023 Aug; 80(9):262. PubMed ID: 37597109
[TBL] [Abstract][Full Text] [Related]
34. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
[TBL] [Abstract][Full Text] [Related]
35. The effects of Dickkopf-4 on the proliferation, differentiation, and apoptosis of osteoblasts.
Hiramitsu S; Terauchi M; Kubota T
Endocrinology; 2013 Dec; 154(12):4618-26. PubMed ID: 24105477
[TBL] [Abstract][Full Text] [Related]
36. JAB1/CSN5 and the COP9 signalosome. A complex situation.
Chamovitz DA; Segal D
EMBO Rep; 2001 Feb; 2(2):96-101. PubMed ID: 11258719
[TBL] [Abstract][Full Text] [Related]
37. CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathway.
Saito N; Sakakibara K; Sato T; Friedman JM; Kufe DW; VonHoff DD; Kawabe T
Mol Cancer Ther; 2014 Dec; 13(12):3013-23. PubMed ID: 25253782
[TBL] [Abstract][Full Text] [Related]
38. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
39. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
40. Roles of COP9 signalosome in cancer.
Lee MH; Zhao R; Phan L; Yeung SC
Cell Cycle; 2011 Sep; 10(18):3057-66. PubMed ID: 21876386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
